Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
36 Results for "
CDX
" in MedChemExpress (MCE) Product Catalog:
Products (36)
36 Results for "CDX" in MCE Product Catalog:
2
2 Cited Publications
Synonyms: CDX-011; CR011-vcMMAE
Research Areas:
Glembatumumab vedotin (CDX-011) is an ADC comprising a fully human IgG2 monoclonal antibody (CR011) directed against glycoprotein NMB (GPNMB) and conjugated to the potent tubulinbinding cytotoxic agent MMAE via a protease-sensitive vc linker. Glembatumumab vedotin has potent anticancer effects .
1
1 Cited Publications
STX-721 is an orally active, irreversible, covalent EGFR exon 20 insertion (ex20ins) inhibitor that selectively targets ex20ins-mutant dynamic protein states. STX-721 potently inhibits the kinase activity of EGFR ex20ins mutants (NPG, ASV, SVD). STX-721 inhibits phosphorylation of EGFR (pEGFR Y1068) and downstream ERK (pERK Thr202/Tyr204), and suppresses proliferation of ex20ins-mutant Ba/F3 cells and human NSCLC cell lines (NCI-H2073 ASV KI, CUTO-14 ASV). STX-721 induces tumor regression in EGFR ex20ins-mutant PDX/CDX models. STX-721 can be used for the study of non-small cell lung cancer (NSCLC) harboring EGFR or HER2 ex20ins mutations .
Cat. No.: HY-P99462
CAS No.: 2438203-51-9
Synonyms: CDX-0159
Target:
Research Areas:
Barzolvolimab (WT IgG1) (CDX-0159) is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab (WT IgG1) specificity and potently inhibits KIT activation by SCF. Barzolvolimab (WT IgG1) can reduce skin mast cells and disease activity in chronic inducible urticaria .
Cat. No.: HY-162919
CAS No.: 2571068-74-9
YK-2168 is a potent and selective CDK9 inhibitor with an IC50 of 5.9 nM. YK-2168 inhibits phosphorylation of the CDK9 substrate pS2-RNA Pol II C-terminal domain. YK-2168 induces apoptosis in tumor cells, suppresses expression of CDK9-regulated genes including MYC and Mcl1, and inhibits tumor growth in CDX mice models. YK-2168 can be used for the research of cancer, such as leukemia .
Cat. No.: HY-P99057
CAS No.: 1393344-72-3
Synonyms: CDX-1127
Research Areas:
Cat. No.: HY-P991240
CAS No.: 2070921-00-3
Synonyms: KTN-3379
Cat. No.: HY-175729
CAS No.: 3036231-62-3
Cyclin A/B RxL-IN-1 is a inhibitor targeting the Cyclin A/B RxL interaction at the hydrophobic patch (HP). Cyclin A/B RxL-IN-1 inhibits Cyclin A with an IC50 of 0.12 μM. Cyclin A/B RxL-IN-1 demonstrates antitumor efficacy in mouse cell line-derived xenograft (CDX) models. CDK-IN-19 can be used for the study of E2F-driven cancers such as small-cell lung cancer (SCLC) .
Cat. No.: HY-176937
CAS No.: 2234239-90-6
HSN608 is an orally active, potent RET G810 mutant inhibitor. HSN608 inhibits G810C, G810R, G810D. HSN608 induces Apoptosis. HSN608 inhibits the Selpercatinib (HY-114370)-resistant RET(G810C) CDX tumors .
Cat. No.: HY-P991510
Target:
Research Areas:
Cat. No.: HY-157210
CAS No.: 3024545-79-4
CDK7-IN-26 (compound 36) is an orally active CDK7 inhibitor (IC50: 7.4 nM). CDK7-IN-26 potently inhibits the growth of triple-negative breast cancer (TNBC) cell line-derived xenograft (CDX) tumors in vivo and inhibits MDA-MB-453 cells in vitro with an IC50 of 0.15 μM .
Cat. No.: HY-RS02429
Target:
Research Areas:
CDX1 Human Pre-designed siRNA Set A contains three designed siRNAs for CDX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS02430
Target:
Research Areas:
CDX2 Human Pre-designed siRNA Set A contains three designed siRNAs for CDX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS02431
Target:
Research Areas:
CDX4 Human Pre-designed siRNA Set A contains three designed siRNAs for CDX4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS25092
Target:
Research Areas:
Cdx2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cdx2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P99057A
CAS No.: 1393344-72-3
Synonyms: CDX-1127 (anti-CD27)
Research Areas:
Cat. No.: HY-P990875
Synonyms: CR014; CDX-014 antibody
Target:
Research Areas:
Cat. No.: HY-170237
CAS No.: 3038863-24-7
Target:
Research Areas:
SIK2/3-IN-1 (Compound 7S) is a selectively inhibitory agent of SIK2/3 with oral activity. SIK2/3-IN-1 can significantly inhibit tumor growth (without any body weight loss) in the MV4-11 AML mice CDX model. SIK2/3-IN-1 can be used in the research of MEF2C-dependent acute myeloid leukemia .
Cat. No.: HY-P991862
Research Areas:
Cat. No.: HY-P990566
CAS No.: 1587257-96-2
Synonyms: Rasdegafusp alfa
Target:
Research Areas:
Cat. No.: HY-170968
CAS No.: 3037323-16-0
EGFR-IN-150 is an EGFR inhibitor that effectively suppresses the phosphorylation of mutant epidermal growth factor receptor (EGFR) and its downstream AKT signaling pathway, thereby exerting antitumor effects and inducing HMOX1 expression to trigger ferroptosis. EGFR-IN-150 exhibits an IC50 of 0.386 μM against the non-small cell lung cancer (NSCLC) cell line H1975, and significantly inhibits colony formation and migration of both H1975 and A549 cells while inducing apoptosis. In addition, EGFR-IN-150 markedly suppresses tumor growth in the H1975 cell-derived xenograft (CDX) mouse model. EGFR-IN-150 holds promise for research related to non-small cell lung cancer .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
